100 related articles for article (PubMed ID: 2292062)
1. Characterization of migration-stimulating factor (MSF): evidence for its role in cancer pathogenesis.
Schor SL; Schor AM
Cancer Invest; 1990; 8(6):665-7. PubMed ID: 2292062
[No Abstract] [Full Text] [Related]
2. Heterogeneity amongst fibroblasts in the production of migration stimulating factor (MSF): implications for cancer pathogenesis.
Schor SL; Grey AM; Picardo M; Schor AM; Howell A; Ellis I; Rushton G
EXS; 1991; 59():127-46. PubMed ID: 1833226
[TBL] [Abstract][Full Text] [Related]
3. Migration stimulating factor (MSF): its structure, mode of action and possible function in health and disease.
Schor SL; Grey AM; Ellis I; Schor AM; Coles B; Murphy R
Symp Soc Exp Biol; 1993; 47():235-51. PubMed ID: 8165568
[TBL] [Abstract][Full Text] [Related]
4. Detection of migration stimulating activity in wound fluid.
Picardo M; Grey AM; McGurk M; Ellis I; Schor SL
Exp Mol Pathol; 1992 Aug; 57(1):8-21. PubMed ID: 1397194
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of action of the migration stimulating factor produced by fetal and cancer patient fibroblasts: effect on hyaluronic and synthesis.
Schor SL; Schor AM; Grey AM; Chen J; Rushton G; Grant ME; Ellis I
In Vitro Cell Dev Biol; 1989 Aug; 25(8):737-46. PubMed ID: 2768134
[TBL] [Abstract][Full Text] [Related]
6. Multi-factorial modulation of IGD motogenic potential in MSF (migration stimulating factor).
Ellis IR; Jones SJ; Staunton D; Vakonakis I; Norman DG; Potts JR; Milner CM; Meenan NA; Raibaud S; Ohea G; Schor AM; Schor SL
Exp Cell Res; 2010 Sep; 316(15):2465-76. PubMed ID: 20403349
[TBL] [Abstract][Full Text] [Related]
7. Purification of the migration stimulating factor produced by fetal and breast cancer patient fibroblasts.
Grey AM; Schor AM; Rushton G; Ellis I; Schor SL
Proc Natl Acad Sci U S A; 1989 Apr; 86(7):2438-42. PubMed ID: 2488545
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast subpopulations as accelerators of tumor progression: the role of migration stimulating factor.
Schor SL
EXS; 1995; 74():273-96. PubMed ID: 8527899
[TBL] [Abstract][Full Text] [Related]
9. Angiogenesis and tumour progression: migration-stimulating factor as a novel target for clinical intervention.
Schor AM; Schor SL
Eye (Lond); 2010 Mar; 24(3):450-8. PubMed ID: 20019766
[TBL] [Abstract][Full Text] [Related]
10. Fetal-like fibroblasts: their production of migration-stimulating factor and role in tumor progression.
Schor SL; Grey AM; Ellis I; Schor AM; Howell A; Sloan P; Murphy R
Cancer Treat Res; 1994; 71():277-98. PubMed ID: 7946952
[No Abstract] [Full Text] [Related]
11. Migration-stimulating factor displays HEXXH-dependent catalytic activity important for promoting tumor cell migration.
Houard X; Germain S; Gervais M; Michaud A; van den Brûle F; Foidart JM; Noël A; Monnot C; Corvol P
Int J Cancer; 2005 Sep; 116(3):378-84. PubMed ID: 15800942
[TBL] [Abstract][Full Text] [Related]
12. Migration stimulating activity in serum of breast cancer patients.
Picardo M; Schor SL; Grey AM; Howell A; Laidlaw I; Redford J; Schor AM
Lancet; 1991 Jan; 337(8734):130-3. PubMed ID: 1670786
[TBL] [Abstract][Full Text] [Related]
13. Migration-stimulating factor (MSF) is over-expressed in non-small cell lung cancer and promotes cell migration and invasion in A549 cells over-expressing MSF.
Deng X; Ma Q; Zhang B; Jiang H; Zhang Z; Wang Y
Exp Cell Res; 2013 Oct; 319(17):2545-53. PubMed ID: 23791940
[TBL] [Abstract][Full Text] [Related]
14. Migration-stimulating factor: a genetically truncated onco-fetal fibronectin isoform expressed by carcinoma and tumor-associated stromal cells.
Schor SL; Ellis IR; Jones SJ; Baillie R; Seneviratne K; Clausen J; Motegi K; Vojtesek B; Kankova K; Furrie E; Sales MJ; Schor AM; Kay RA
Cancer Res; 2003 Dec; 63(24):8827-36. PubMed ID: 14695199
[TBL] [Abstract][Full Text] [Related]
15. Effect of tenascin and fibronectin on the migration of human corneal fibroblasts.
Schmidinger G; Hanselmayer G; Pieh S; Lackner B; Kaminski S; Ruhswurm I; Skorpik C
J Cataract Refract Surg; 2003 Feb; 29(2):354-60. PubMed ID: 12648649
[TBL] [Abstract][Full Text] [Related]
16. Tumor-conditioned macrophages secrete migration-stimulating factor: a new marker for M2-polarization, influencing tumor cell motility.
Solinas G; Schiarea S; Liguori M; Fabbri M; Pesce S; Zammataro L; Pasqualini F; Nebuloni M; Chiabrando C; Mantovani A; Allavena P
J Immunol; 2010 Jul; 185(1):642-52. PubMed ID: 20530259
[TBL] [Abstract][Full Text] [Related]
17. Human peri-tumoral and lung fibroblasts produce paracrine motility factors for recently established human sarcoma cell strains.
Hu M; Pollock RE; Nakamura T; Nicolson GL
Int J Cancer; 1995 Sep; 62(5):585-92. PubMed ID: 7665230
[TBL] [Abstract][Full Text] [Related]
18. Migration-stimulating factor as a novel biomarker in salivary gland tumours.
Aljorani LE; Bankfalvi A; Carey FA; Harada K; Ohe G; Jones SJ; Ellis IR; Schor SL; Schor AM
J Oral Pathol Med; 2011 Nov; 40(10):747-54. PubMed ID: 21481007
[TBL] [Abstract][Full Text] [Related]
19. [Effect of carcinoma-associated fibroblasts on cancer occurrence and development].
Peng Q; Sun Y; Zhao L; Wang L; Peng H; Liu M
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2013 Feb; 30(1):200-3. PubMed ID: 23488164
[TBL] [Abstract][Full Text] [Related]
20. Effects of macrophage migration inhibitory factor and macrophage migration stimulatory factor on function and survival of foetal dopaminergic grafts in the 6-hydroxydopamine rat model of Parkinson's disease.
Schwarz SC; Schwarz J; Sautter J; Oertel WH
Exp Brain Res; 1998 May; 120(1):95-103. PubMed ID: 9628407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]